Defense Minister Naftali Bennett on Monday said he witnessed a “significant breakthrough” by Israel’s defense biological research institute in developing an antibody to COVID-19, as the researchers wrapped up the development phase and moved to patent and mass produce the potential treatment.
Bennett visited the labs of the Israel Institute for Biological Research (IIBR), a secretive unit that works under the Prime Minister’s Office, in Ness Ziona and was shown the “antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill,” according to a statement from his office.
Full Story (The Times of Israel)
